AIMIL Pharmaceuticals has announced its strategic expansion in the international markets. The company aims to expand its operations into 25 countries, including Europe, the CIS region, the Middle East, Africa, and the Indian Ocean islands.

Dr Ikshit Sharma, Director, AIMIL Pharmaceuticals said, "This expansion plan is in line with the ever-increasing global demand for authentic science-based ayurvedic products for better health. Our products with ECOCERT certified organic herbs would ensure the delivery of premium quality, safe and result-oriented products across various categories such as healthcare, personal care, wellness, and veterinary sectors. We aim to introduce more innovative products as per markets' needs and target 100 countries in the next two financial years. We have also constituted a team headed by Amit Dixit, Global CEO to enhance our focus on international business and expect to generate a revenue of $15 million from this vertical in the next five years."